ADIAL PHARMACEUTICALS, INC.·4

Feb 25, 2:54 PM ET

Claiborne Cary J 4

4 · ADIAL PHARMACEUTICALS, INC. · Filed Feb 25, 2022

Insider Transaction Report

Form 4
Period: 2022-02-23
Claiborne Cary J
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option

    2022-02-23+6,6676,667 total
    Exercise: $2.00From: 2022-03-23Exp: 2032-02-22Common Stock (6,667 underlying)
Footnotes (1)
  • [F1]The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022.

Documents

2 files